Advertisement
U.S. Markets close in 3 hrs 14 mins

OptiBiotix Health Plc (OPTI.L)

LSE - LSE Delayed Price. Currency in GBp (0.01 GBP)
12.50-0.12 (-0.99%)
At close: 03:25PM GMT

OptiBiotix Health Plc

Innovation Centre
Innovation Way Heslington
York YO10 5DG
United Kingdom

https://optibiotix.com

Sector(s)Healthcare
IndustryBiotechnology
Full Time Employees10

Key Executives

NameTitlePayExercisedYear Born
Mr. Stephen Patrick O'HaraFounder, CEO & Executive Director147kN/A1960
Dr. Sofia KolydaExecutive Director of Research & Development and Executive Director47kN/A1973
Mr. Graham Lloyd MyersExecutive Director4kN/AN/A
Mr. David Jonathan Blain ACAActing Finance DirectorN/AN/A1962
Paul CanningsHead of Operations & QualityN/AN/AN/A
Kevin James NewmanCorporate Development DirectorN/AN/AN/A
Mr. Karl BurkittMarketing DirectorN/AN/AN/A
Mr. Mark Kingsley CollingbourneSecretaryN/AN/A1966
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in GBp.

Description

OptiBiotix Health Plc, a life sciences company, engages in the discovery and development of microbiome modulators in the United Kingdom, the United States, China, and internationally. The company identifies and develops microbial strains, compounds, and formulations for use in food ingredients, supplements, and active compounds that can impact human physiology and derive potential health benefits. Its products include Slimbiome, which offers a healthy and hunger-free weight management system; SlimBiome Medical, a natural supplement for weight management; Lactobacillus plantarum LPLDL, a probiotic that aids elements of cardiovascular and wellbeing; CholBiome, a food supplement for reducing cholesterol and blood pressure; LPGOS, a galactooligosaccharide that is used in food products and applications, which helps reduce cardiovascular risk factors and enhance health; and Sweetbiotix, a low calorie sweetener for food and beverages. The company's products prevent and manage chronic lifestyle disorders, including obesity, hypercholesterolemia, and diabetes. The company was formerly known as Ducat Ventures PLC and changed its name to OptiBiotix Health Plc in August 2014. OptiBiotix Health Plc was incorporated in 2006 and is headquartered in York, the United Kingdom.

Corporate Governance

OptiBiotix Health Plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.